Trial Profile
Intralymphatic specific immunotherapy - as a new treatment for grass pollen allergy sufferers. [Intralymfatisk specifik immunterapi - som ny behandlingsmetode til graespollenallergikere].
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Apr 2013
Price :
$35
*
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Grass pollen hypersensitivity
- Focus Therapeutic Use
- Acronyms ILIT
- 09 Feb 2013 Status changed from recruiting to completed.
- 28 Jun 2011 New trial record